|Aoxing Pharmaceutical Company, Inc.|
No.1, Nanhuan Eastern Road
China - Map
Phone: 86 311 8519 6888
Fax: 86 311 8519 6969
Aoxing Pharmaceutical Co., Inc., a specialty pharmaceutical company, engages in research, development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the Peoples Republic of China. The companys principal products comprise Zhongtongan, a capsule of herbal extraction for the indication of oral and dental pain; and Bismuth Potassium Citrate, an oral solution for the treatment of chronic gastritis and stomachache due to excessive stomach acid. Its products under development include Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone that has completed phase I and phase II clinical trial for the treatment of opioid dependence; and Tilidine/Naloxone, which is in Phase II clinical trials to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was founded in 1655 and is headquartered in Shijiazhuang, China.
|Mr. Zhenjiang Yue ,
Chairman and Chief Exec. Officer
|Dr. Zheng Chen Ph.D., CFA, MBA,
Chief Financial Officer
|Mr. Guoan Zhang ,
Chief Accounting Officer and Sr. VP of Fin.
|Ms. Yunlan Tang ,
| Wei Zhang ,
|Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|